We're excited to share our newly improved newsletter!
Stay informed with insights on longevity, healthspan, and more. Join a growing community focused on evidence-based science and healthier living.
Subscribe now: foundation.us20.list-manage.…
#Aging #Longevity #Biotech
At 2026 @ARDD_Meeting: @novonordisk and @EliLillyandCo reported GLP-1 users’ aging-clock readings ~2–3 years below placebo. @ARPA_H is testing semaglutide + two @FDA-approved drugs in adults 60+.
@techreview #longevity #aging
technologyreview.com/2026/10…
Peptides are being widely discussed, but how strong is the science?
Our latest Hype vs. Reality article explores GLP-1 medicines, separating established clinical evidence from promising but preliminary findings.
Read more: longevity.foundation/tpost/0…
#peptides #GLP1 #longevity
At @ARDD_Meeting 2026, the @FDA said #aging and #longevity will be included in its next regulatory science agenda. Officials discussed trials, biomarkers and collaboration.
Read the @LifespanRI article by @ArkadyMazin: lifespan.io/fda-leaders-name…
The Longevity Science Foundation retweeted
Day 1 of #ARDD2026 opens at Harvard. George Daley, Dean of Harvard Medical School, kicks off the 13th Aging Research & Drug Discovery Meeting. Full program: agingpharma.org/program2026
ARDD 2026 is here in Boston, Oct 1-3. Proud of our ties with @ARDD_Meeting: SAB members @biogerontology, @Dr_Bischof; grantee PI @ScheibyeKnudsen; founders Garri Zmudze & Sergey Jakimov (@hqlongevc); organizer @InSilicoMeds.
Register and learn more: agingpharma.org/
Peptides are everywhere in conversations about weight loss, recovery, skin health, metabolism, and #longevity. But what are they, really? Our article explores what #peptides are, how they work, and how to separate science from hype.
Read more: longevity.foundation/tpost/2…
Colleagues from @metabesity and @APACLongevity are hosting the 2026 Asia-Pacific Healthy Longevity International Summit, Oct 1-4 in Hong Kong, with 1,000+ attendees and speakers including our Scientific Advisors, @mkaeberlein and @AndreaBMaier. Learn more: apaclongevitysociety.org/#/m…
Six proteomic #aging clocks showed reductions in predicted biological age among rentosertib-treated participants in a Phase 2a trial of @InsilicoMedicine drug for IPF. Congratulations to Insilico CEO and our scientific advisor @biogerontology and the team! nature.com/articles/s41587-0…
For the first time, people 65+ outnumber children ≤5 worldwide, @axios reports. Longer lives are an achievement, but longer life does not always mean longer health. As populations age, investing in #healthspan is increasingly urgent.
axios.com/2026/09/03/older-a…
#aging #longevity
The @USC has received a $7.5M @NIH grant to establish GeroSCORE, advancing research into sex differences in #aging, including #menopause and brain aging.
Progress in the field is being made, but major gaps remain. Help fund women’s health research: longevity.foundation/investe…
Thank you for your support @LifespanNews! Learn more about our Invested in Her campaign: longevity.foundation/investe…
The Longevity Science Foundation (@longescience) is extending the deadline for its Invested in Her campaign to October 1, 2026, as they work to support early-stage research into ovarian aging and menopause.
👉 Read more: lifespan.io/invested-in-her-…
Endometriosis affects ~190 million people worldwide, yet diagnosis can take years, and major #research gaps remain. Why is it so difficult to diagnose and treat?
Our latest SLIC article explores #endometriosis: longevity.foundation/tpost/u…
A vaccine for cancer? Moderna and Merck’s personalized mRNA cancer vaccine, combined with Keytruda, has met key efficacy endpoints in a Phase III melanoma trial.
What does a “cancer vaccine” mean, and could it help prevent #cancer from returning?
longevity.foundation/tpost/t…
New deadline: October 1.
Invested in Her is raising $250,000 for research into ovarian #aging and #menopause. 100% of donations go directly to research.
Help close the research gap: longevity.foundation/investe…
Invested in Her brought together leaders in NYC to explore challenges facing women’s health and opportunities for change. We are raising $250,000 for research on ovarian #aging and #menopause, with donations going directly to research.
Recap: longevity.foundation/news/tp… #longevity
4 days left until Invested in Her in NYC with 10 seats remaining. On August 14 we bring together investors, clinicians, and advocates at 7 World Trade Center.
Register: longevity.foundation/iih26
Donations support our $250,000 campaign for research into ovarian aging and menopause
We're pleased to welcome J.P. Morgan Private Bank as a Gold Sponsor of Invested in Her, an event advancing women's health research on Aug 14th in NYC.
Register: longevity.foundation/iih26
Learn more: privatebank.jpmorgan.com/nam…
The agenda for Invested in Her event on 8/14 is live. Join us in NYC for an afternoon focused on advancing women's health.
Part of our Invested in Her campaign, the event supports research into #menopause and ovarian #aging. Only 85 seats are available.
longevity.foundation/iih26
On Aug 14 we host "Invested in Her" in NYC, bringing together investors, clinicians, philanthropists, and operators advancing women's health.
85 seats. Panels, networking, and leaders supporting research into ovarian #aging and #menopause. Register: longevity.foundation/iih26
Women's health platform Ovum has raised AUD $4 million (~USD $2.77 million) in seed funding to expand its AI-powered platform supporting women across different life stages.
More: forbes.com.au/news/entrepren…
#womenshealth #menopause #longevity























